Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allison

Showing results (541-550 of 647) with videos related to

Pageof 65
Sort By:
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 17, 2006
Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind studyDileep N Lobo, Robert N Williams, Neil T Welch, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Nature Immunology|June 11, 2003
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Norihiko Watanabe, Maya Gavrieli, John R Sedy, et al.
Journal of Dental Research|December 21, 2019
<i>The Lancet</i> Oral Health Series: Implications for Oral and Dental ResearchR G Watt, B Daly, P Allison, et al.
Cancer Immunology Research|June 6, 2024
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote TumorigenesisSusana Castro-Pando, Rian M Howell, Le Li, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Applied and Environmental Microbiology|October 19, 2010
Effects of engineered cerium oxide nanoparticles on bacterial growth and viabilityDale A Pelletier, Anil K Suresh, Gregory A Holton, et al.
The Journal of Experimental Medicine|July 31, 2013
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanomaTyler R Simpson, Fubin Li, Welby Montalvo-Ortiz, et al.
Pageof 65

Showing results (541-550 of 647) with videos related to

Sort By:
Pageof 65
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 17, 2006
Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind studyDileep N Lobo, Robert N Williams, Neil T Welch, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironmentSumit K Subudhi, Bilal A Siddiqui, Ana M Aparicio, et al.
Nature Immunology|June 11, 2003
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Norihiko Watanabe, Maya Gavrieli, John R Sedy, et al.
Journal of Dental Research|December 21, 2019
<i>The Lancet</i> Oral Health Series: Implications for Oral and Dental ResearchR G Watt, B Daly, P Allison, et al.
Cancer Immunology Research|June 6, 2024
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote TumorigenesisSusana Castro-Pando, Rian M Howell, Le Li, et al.
Cancer Immunology Research|September 5, 2014
Combining radiation and immunotherapy: a new systemic therapy for solid tumors?Chad Tang, Xiaohong Wang, Hendrick Soh, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Applied and Environmental Microbiology|October 19, 2010
Effects of engineered cerium oxide nanoparticles on bacterial growth and viabilityDale A Pelletier, Anil K Suresh, Gregory A Holton, et al.
The Journal of Experimental Medicine|July 31, 2013
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanomaTyler R Simpson, Fubin Li, Welby Montalvo-Ortiz, et al.
Pageof 65